Jose M. Adrover

Jose earned his PhD at the Spanish National Cardiovascular Research Centre (CNIC) in Madrid, working on circadian control of innate immunity under homeostatic and inflammatory conditions (with a focus on cardiovascular disease) in the laboratory of Andres Hidalgo.

He was then a Cancer Research Institute (CRI) Irvington postdoctoral fellow in the laboratory of Mikala Egeblad at Cold Spring Harbor Laboratory in New York, where he studied the role of neutrophils and NETs in acute lung injury and cancer progression.

He later became a research associate at Johns Hopkins University School of Medicine, where he studied the role of neutrophils and vascular inflammation in cancer progression. In 2024, he became a Crick/BHF Group Leader at the Francis Crick Institute with support from the British Heart Foundation.